ArticleFrontiers in cardiovascular medicine2026
Association between the atherogenic index of plasma and prehypertension or hypertension among adults in Fujian, China: a population-based cross-sectional study.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Elevated blood pressure may share a similar pathophysiology with cardiovascular disease (CVD). Although the atherogenic index of plasma (AIP) has been associated with hypertension and CVD, evidence on the association between the AIP and prehypertension risk remains limited. This study aims to explore the relationship of the AIP with the risks of prehypertension and hypertension in a Chinese population. Methods: This study was based on a population-based cross-sectional survey data of Fujian province and was conducted between August 2020 and April 2021. The association between the AIP and prehypertension/hypertension risk was assessed through multivariate logistic regression. Four-knot restricted cubic splines (RCS) were performed to examine the potential dose-response relationships. Subgroup analyses were used to assess the heterogeneity of the associations across different population subgroups, and an receiver operating characteristic (ROC) curve analysis was used to determine the cutoff values for predicting prehypertension/hypertension. The mediating roles of the two types of inflammatory indicators were analyzed through mediation analysis. Several sensitivity analyses were also conducted to further assess the robustness of the results. Results: A total of 9,473 adults were included in the final analysis, including 3,273 diagnosed with prehypertension and 3,248 with hypertension. Overall, participants with elevated AIP levels demonstrated higher prehypertension detection rates and hypertension prevalence (all Conclusion: The AIP is positively associated with the risk of prehypertension and hypertension among participants ≥ 18 years of age in China, with white blood cell count potentially mediating a part of this association, which indicates that monitoring and maintaining optimal AIP levels may help prevent the deterioration of blood pressure categories.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.